Verify regulatory 503A compliance and calculate out-of-pocket savings for compounded Tirzepatide & Semaglutide in California compared to retail commercial list prices ($1050/mo).
Status: Legally Available via Strict 503A Patient-Specific Prescription
Under California law, state-licensed 503A compounding pharmacies may dispense customized peptide formulations (such as compounded Tirzepatide or Semaglutide) with a valid, patient-specific prescription issued following an appropriate medical consultation.
Statutory Citation: Cal. Bus. & Prof. Code § 4127 & California State Board of Pharmacy Compounding Standards
Under California law, state-licensed 503A compounding pharmacies may dispense customized peptide formulations (such as compounded Tirzepatide or Semaglutide) with a valid, patient-specific prescription issued following an appropriate medical consultation.
Yes. Compounded GLP-1 medications are legal in California when dispensed by a licensed 503A compounding pharmacy with a valid physician prescription formulated for an individual patient.
Patients paying out-of-pocket typically save between $700 and $850 per month compared to brand-name retail list prices ($1,050+/mo).
Browse deep clinical analysis and metabolic decision models on Groundwork.